- AXSM -1.60%
Axsome Therapeutics, Inc. (NASDAQ:AXSM) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
Yahoo Finance · 2 days ago
Open | 74.15 |
High | 75.95 |
Low | 72.40 |
Mkt Cap | 3.5B |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 73.68 |
52 Wk. Low | 55.02 |
52 Wk. High | 98.40 |
Related stocks
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 75M | 20.70% ▼ |
Net Income | -68.36M | - |
Diluted EPS | -1.44 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$1.33 | - |
Q1 2024 | -$1.20 | -$1.44 |
Q4 2023 | -$1.17 | -$2.08 |
S&P 500^GSPC | 5,222.68+8.60 (+0.16%) |
Dow 30^DJI | 39,512.84+125.08 (+0.32%) |
Nasdaq^IXIC | 16,340.87-5.40 (-0.03%) |
Novavax, Inc.NVAX | 8.88+98.66% |
149.26+4.53% | |
AEye, Inc.LIDR | 2.5800+118.64% |